Danaher to Buy Masimo for $180/Share in a $9.9B Acquisition

1 min read
Source: Business Wire
TL;DR Summary

Danaher will acquire Masimo for $180 per share in cash, valuing the deal at about $9.9 billion. The boards have approved the transaction, Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment, and the deal is expected to close in the second half of 2026 subject to regulatory approvals and other customary closing conditions.

Share this article

Reading Insights

Total Reads

0

Unique Readers

3

Time Saved

12 min

vs 12 min read

Condensed

98%

2,37058 words

Want the full story? Read the original article

Read on Business Wire